ArticleActa pharmaceutica Sinica. B2025

Innovative discovery and mechanistic validation of HyT-PD ligands for selective CDK9-targeted protein degradation.

Yizhan Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.